全文获取类型
收费全文 | 8318篇 |
免费 | 528篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 223篇 |
妇产科学 | 239篇 |
基础医学 | 1220篇 |
口腔科学 | 172篇 |
临床医学 | 762篇 |
内科学 | 2018篇 |
皮肤病学 | 229篇 |
神经病学 | 947篇 |
特种医学 | 184篇 |
外科学 | 783篇 |
综合类 | 19篇 |
一般理论 | 2篇 |
预防医学 | 645篇 |
眼科学 | 112篇 |
药学 | 523篇 |
中国医学 | 19篇 |
肿瘤学 | 742篇 |
出版年
2024年 | 8篇 |
2023年 | 117篇 |
2022年 | 213篇 |
2021年 | 379篇 |
2020年 | 255篇 |
2019年 | 297篇 |
2018年 | 322篇 |
2017年 | 237篇 |
2016年 | 284篇 |
2015年 | 324篇 |
2014年 | 409篇 |
2013年 | 535篇 |
2012年 | 784篇 |
2011年 | 793篇 |
2010年 | 419篇 |
2009年 | 369篇 |
2008年 | 557篇 |
2007年 | 507篇 |
2006年 | 447篇 |
2005年 | 387篇 |
2004年 | 326篇 |
2003年 | 268篇 |
2002年 | 217篇 |
2001年 | 45篇 |
2000年 | 30篇 |
1999年 | 44篇 |
1998年 | 39篇 |
1997年 | 31篇 |
1996年 | 27篇 |
1995年 | 22篇 |
1994年 | 16篇 |
1993年 | 9篇 |
1992年 | 20篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 14篇 |
1988年 | 13篇 |
1987年 | 7篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 4篇 |
1981年 | 9篇 |
1980年 | 4篇 |
1979年 | 8篇 |
1977年 | 8篇 |
1976年 | 4篇 |
1972年 | 6篇 |
1969年 | 4篇 |
排序方式: 共有8897条查询结果,搜索用时 14 毫秒
81.
Elisa Docampo Emiliano Giardina Eva Riveira‐Muoz Rafael de Cid Georgia Escaramís Carlo Perricone Jos L. Fernndez‐Sueiro Joan Maym Miguel A. Gonzlez‐Gay Francisco J. Blanco Ulrike Hüffmeier M. Pilar Lisbona Javier Martín ngel Carracedo Andr Reis Raquel Rabionet Giuseppe Novelli Xavier Estivill 《Arthritis \u0026amp; Rheumatology》2011,63(7):1860-1865
Objective
The LCE3C_LCE3B‐del variant is associated with psoriasis and rheumatoid arthritis. Its role in psoriatic arthritis (PsA) is unclear, however, as shown by 3 recent studies with contradictory results. In order to investigate whether LCE3C_LCE3B‐del constitutes a risk factor for PsA susceptibility, we first tested this variant in patients with PsA from Spanish and Italian populations and then performed a meta‐analysis including the previous case–control studies.Methods
We genotyped LCE3C_LCE3B‐del and its tag single‐nucleotide polymorphism (SNP), rs4112788, in an original discovery cohort of 424 Italian patients with PsA and 450 unaffected control subjects. A Spanish replication cohort consisting of 225 patients with PsA and 469 control subjects was also genotyped. A meta‐analysis considering 7,758 control subjects and 2,325 patients with PsA was also performed.Results
We observed a significant association between PsA and the LCE3C_LCE3B‐del tag SNP in the Italian and Spanish cohorts, with an overall corrected P value of 0.00019 and a corresponding odds ratio of 1.35 (95% confidence interval 1.14–1.59). Stratified analyses by subphenotype indicated a stronger association for patients with oligoarticular disease. Meta‐analysis including data from all previous published studies confirmed an association of PsA with the LCE3C_LCE3B‐del tag SNP.Conclusion
LCE3C_LCE3B‐del is a susceptibility factor for PsA, confirming the existence of a shared risk factor involving the epidermal skin barrier in autoimmune disorders.82.
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 总被引:4,自引:0,他引:4
Gordeuk VR Caleffi A Corradini E Ferrara F Jones RA Castro O Onyekwere O Kittles R Pignatti E Montosi G Garuti C Gangaidzo IT Gomo ZA Moyo VM Rouault TA MacPhail P Pietrangelo A 《Blood cells, molecules & diseases》2003,31(3):299-304
The product of the SLC40A1 gene, ferroportin 1, is a main iron export protein. Pathogenic mutations in ferroportin 1 lead to an autosomal dominant hereditary iron overload syndrome characterized by high serum ferritin concentration, normal transferrin saturation, iron accumulation predominantly in macrophages, and marginal anemia. Iron overload occurs in both the African and the African-American populations, but a possible genetic basis has not been established. We analyzed the ferroportin 1 gene in 19 unrelated patients from southern Africa (N = 15) and the United States (N = 4) presenting with primary iron overload. We found a new c. 744 C-->T (Q248H) mutation in the SLC40A1 gene in 4 of these patients (3 Africans and 1 African-American). Among 22 first degree family members, 10 of whom were Q248H heterozygotes, the mutation was associated with a trend to higher serum ferritin to amino aspartate transferase ratios (means of 14.8 versus 4.3 microg/U; P = 0.1) and lower hemoglobin concentrations (means of 11.8 versus 13.2 g/dL; P = 0.1). The ratio corrects serum ferritin concentration for alcohol-induced hepatocellular damage. We also found heterozygosity for the Q248H mutation in 7 of 51 (14%) southern African community control participants selected because they had a serum ferritin concentration below 400 microg/L and in 5 of 100 (5%) anonymous African-Americans, but we did not find the change in 300 Caucasians with normal iron status and 25 Caucasians with non-HFE iron overload. The hemoglobin concentration was significantly lower in the African community controls with the Q248H mutation than in those without it. We conclude that the Q248H mutation is a common polymorphism in the ferroportin 1 gene in African populations that may be associated with mild anemia and a tendency to iron loading. 相似文献
83.
Enrico Cristante Simon McArthur Claudio Mauro Elisa Maggioli Ignacio A. Romero Marzena Wylezinska-Arridge Pierre O. Couraud Jordi Lopez-Tremoleda Helen C. Christian Babette B. Weksler Andrea Malaspina Egle Solito 《Proceedings of the National Academy of Sciences of the United States of America》2013,110(3):832-841
The blood–brain barrier (BBB), a critical guardian of communication between the periphery and the brain, is frequently compromised in neurological diseases such as multiple sclerosis (MS), resulting in the inappropriate passage of molecules and leukocytes into the brain. Here we show that the glucocorticoid anti-inflammatory messenger annexin A1 (ANXA1) is expressed in brain microvascular endothelial cells, where it regulates BBB integrity. In particular, ANXA1−/− mice exhibit significantly increased BBB permeability as a result of disrupted interendothelial cell tight junctions, essentially related to changes in the actin cytoskeleton, which stabilizes tight and adherens junctions. This situation is reminiscent of early MS pathology, a relationship confirmed by our detection of a selective loss of ANXA1 in the plasma and cerebrovascular endothelium of patients with MS. Importantly, this loss is swiftly restored by i.v. administration of human recombinant ANXA1. Analysis in vitro confirms that treatment of cerebrovascular endothelial cells with recombinant ANXA1 restores cell polarity, cytoskeleton integrity, and paracellular permeability through inhibition of the small G protein RhoA. We thus propose ANXA1 as a critical physiological regulator of BBB integrity and suggest it may have utility in the treatment of MS, correcting BBB function and hence ameliorating disease.The presence of narrow and dense tight junctions between adjacent endothelial cells is peculiar to the cerebral vasculature, and their integrity is essential for the maintenance of correct blood–brain barrier (BBB) function as the primary regulator of cross-talk between the brain and the rest of the body (1). Increasing evidence indicates that the integrity of this structural and functional barrier is compromised in neurological conditions such as multiple sclerosis (MS), Alzheimer’s, and Parkinson diseases, leading to the failure of the normal mechanisms controlling passage of substances into the brain (2) and to the sensitization and/or worsening of pathologic conditions. Pharmacological intervention to prevent or correct BBB alteration in such diseases is a difficult task, but potential therapeutic leads can be gained from the study of endogenous mediators regulating barrier integrity.Annexin A1 (ANXA1) is an important anti-inflammatory protein, principally known as a regulator of peripheral leukocyte migration and a promoter of macrophage phagocytosis (3). ANXA1 is expressed in several cell types within the brain, including ependyma and microglia, but in particular in the endothelium of the brain microvasculature (4), although its role in these cells remains obscure. We have previously shown glucocorticoids to up-regulate expression of ANXA1 in the cerebral endothelium (5), and, given that glucocorticoids enhance BBB tightness (6), we hypothesized that ANXA1 may play a role in the regulation of BBB permeability. Through combined in vitro and in vivo approaches, we have identified a dual role for ANXA1 in organizing the interendothelial cell tight and adherens junctions: (i) endogenously through its interactions with the actin cytoskeleton, and (ii) exogenously in an autocrine/paracrine via formyl peptide receptor 2 (FPR2), leading to the down-regulation of RhoA GTPase activity. Together, these two actions of ANXA1 regulate paracellular permeability in the BBB, and provide a major contribution to BBB integrity and function. Moreover, we describe a selective down-regulation of ANXA1 expression in the plasma and cerebral microvascular endothelia of patients with MS, strongly suggesting an explanation for the BBB dysfunction that is a typical early sign of this disease. All these findings pinpoint ANXA1 as a critical component of the BBB endothelium contributing to barrier integrity. Its autoparacrine role and the loss in patients with MS highlight the potential utility of the protein or its peptidomimetics as a therapeutic target for pathologic processes characterized by compromised BBB function, such as MS. 相似文献
84.
Montagnani M Abrahamsson A Gälman C Eggertsen G Marschall HU Ravaioli E Einarsson C Dawson PA 《World journal of gastroenterology : WJG》2006,12(47):7710-7714
INTRODUCTION Bile acids are synthesized from cholesterol in the liver and secreted into the small intestine, where they facilitate absorption of fat, fat-soluble vitamins and cholesterol[1]. The bile acids are then reabsorbed from the intestine and return… 相似文献
85.
Nevas M Lindström M Virtanen A Hielm S Kuusi M Arnon SS Vuori E Korkeala H 《Journal of clinical microbiology》2005,43(1):511-513
Clostridium botulinum type B was detected by multiplex PCR in the intestinal contents of a suddenly deceased 11-week-old infant and in vacuum cleaner dust from the patient's household. C. botulinum was also isolated from the deceased infant's intestinal contents and from the household dust. The genetic similarity of the two isolates was demonstrated by pulsed-field gel electrophoresis and randomly amplified polymorphic DNA analysis, thereby confirming that dust may act as a vehicle for infant botulism that results in sudden death. 相似文献
86.
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: Different genetic mechanisms but equivalent poorer clinical outcome 下载免费PDF全文
Anna Puiggros Marta Venturas Marta Salido Gonzalo Blanco Concepcin Fernandez‐Rodriguez Rosa Collado Alberto Valiente Neus Ruiz‐Xivill Ana Carri Francisco Jos Ortuo Elisa Luo María Jos Calasanz María Teresa Ardanaz María ngeles Pin Elisabet Talavera María Teresa Gonzlez Margarita Ortega Isabel Marugn Ana Ferrer Eva Gimeno Beatriz Bellosillo Julio Delgado Jos ngel Hernndez Jesús María Hernndez‐Rivas Blanca Espinet 《Genes, chromosomes & cancer》2014,53(9):788-797
Deletion of 13q14 as the sole abnormality is a good prognostic marker in chronic lymphocytic leukemia (CLL). Nonetheless, the prognostic value of reciprocal 13q14 translocations [t(13q)] with related 13q losses has not been fully elucidated. We described clinical and biological characteristics of 25 CLL patients with t(13q), and compared with 62 patients carrying interstitial del(13q) by conventional G‐banding cytogenetics (CGC) [i‐del(13q)] and 295 patients with del(13q) only detected by fluorescence in situ hybridization (FISH) [F‐del(13q)]. Besides from the CLL FISH panel (D13S319, CEP12, ATM, TP53), we studied RB1 deletions in all t(13q) cases and a representative group of i‐del(13q) and F‐del(13q). We analyzed NOTCH1, SF3B1, and MYD88 mutations in t(13q) cases by Sanger sequencing. In all, 25 distinct t(13q) were described. All these cases showed D13S319 deletion while 32% also lost RB1. The median percentage of 13q‐deleted nuclei did not differ from i‐del(13q) patients (73% vs. 64%), but both were significantly higher than F‐del(13q) (52%, P < 0.001). Moreover, t(13q) patients showed an increased incidence of biallelic del(13q) (52% vs. 11.3% and 14.9%, P < 0.001) and higher rates of concomitant 17p deletion (37.5% vs. 8.6% and 7.2%, P < 0.001). RB1 involvement was significantly higher in the i‐del(13q) group (79%, P < 0.001). Two t(13q) patients (11.8%) carried NOTCH1 mutations. Time to first treatment in t(13q) and i‐del(13q) was shorter than F‐del(13q) (67, 44, and 137 months, P = 0.029), and preserved significance in the multivariate analysis. In conclusion, t(13q) and del(13q) patients detected by CGC constitute a subgroup within the 13q‐deleted CLL patients associated with a worse clinical outcome. © 2014 Wiley Periodicals, Inc. 相似文献
87.
Vancheri C Gili E Failla M Mastruzzo C Salinaro ET Lofurno D Pistorio MP La Rosa C Caruso M Crimi N 《The Journal of allergy and clinical immunology》2005,116(6):1242-1248
BACKGROUND: The identification of factors mediating the transition of lung fibroblasts into myofibroblasts is considered fundamental in the comprehension of abnormal reparative processes. Bradykinin, a mediator known for its proinflammatory action, is able to induce cytokine production and contractility in fibroblast cultures. OBJECTIVES: In this study the ability of bradykinin to drive fibroblast into a myofibroblast phenotype at the cellular and molecular level was evaluated. METHODS: alpha-Smooth muscle actin (alpha-SMA) expression and TGF-beta in bradykinin stimulated fibroblasts were tested by means of flow cytometry, Western blot, and RT-PCR. Cell proliferation and collagen production were evaluated by the colorimetric methylthiazol tetrazolium assay and sirius red assay, respectively. Which bradykinin receptor mediates the expression of alpha-SMA was evaluated using selective B1 and B2 blocking agents. Furthermore, the effect of bradykinin on extracellular signal-regulated kinase 1/2 phosphorylation was explored. RESULTS: Bradykinin caused in lung fibroblasts a significant increase in alpha-SMA at the cellular and molecular level. The B2 receptor was held responsible for this effect because a specific receptor antagonist had entirely blocked this effect. Bradykinin was able to induce fibroblast proliferation and collagen production. Bradykinin significantly activated mitogen-activated protein kinase pathway by phosphorylating extracellular signal-regulated kinase 1/2, whereas PD98059, a specific inhibitor, was able to block myofibroblast induction. Although bradykinin induced an increase of TGF-beta on fibroblasts, the blockage of this cytokine did not alter alpha-SMA expression. CONCLUSION: The data support the hypothesis that bradykinin may be involved in bronchial remodeling and lung fibrosis beyond its well recognized proinflammatory activity, also suggesting a new potential therapeutic strategy to control altered reparatory processes. 相似文献
88.
Vincenzo Duino Luigi Fiocca Giuseppe Musumeci Emilia D’Elia Mauro Gori Elisa Cerchierini Orazio Valsecchi Michele Senni 《Medicine》2015,94(20)
Functional mitral regurgitation (FMR) is frequent in patients with heart failure (HF). It develops as a consequence of left ventricle (LV) geometry alterations, causing imbalance between increased tethering forces and decreased closing forces exerted on the mitral valve apparatus during systole.FMR is known to change at rest and during effort, due to preload–afterload changes, myocardial ischemia, and/or LV dysfunction. Despite optimized medical therapy, an FMR can be responsible of shortness of breath limiting quality of life and decompensation. In this report, we present a case of dynamic FMR treated with MitraClip.MitraClip implantation is a successful and innovative opportunity for HF patients with FMR. 相似文献
89.
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome
Marco Cattalini Jessica Galli Laura Andreoli Ivana Olivieri Giada Ariaudo Micaela Fredi IAGSA study group Simona Orcesi Angela Tincani Elisa Fazzi 《Journal of clinical immunology》2016,36(7):693-699